Bedell Frazier Investment Counselling’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,719
| Closed | -$201K | – | 102 |
|
|
2022
Q3 | $201K | Sell |
1,719
-430
| -20% | -$50.3K | 0.06% | 94 |
|
|
2022
Q2 | $253K | Sell |
2,149
-183
| -8% | -$21.5K | 0.08% | 72 |
|
|
2022
Q1 | $304K | Sell |
2,332
-48
| -2% | -$6.26K | 0.08% | 78 |
|
|
2021
Q4 | $363K | Sell |
2,380
-461
| -16% | -$70.3K | 0.09% | 81 |
|
|
2021
Q3 | $459K | Sell |
2,841
-8
| -0.3% | -$1.29K | 0.13% | 63 |
|
|
2021
Q2 | $466K | Sell |
2,849
-49
| -2% | -$8.02K | 0.12% | 68 |
|
|
2021
Q1 | $436K | Sell |
2,898
-143
| -5% | -$21.5K | 0.12% | 66 |
|
|
2020
Q4 | $461K | Buy |
3,041
+375
| +14% | +$56.8K | 0.14% | 62 |
|
|
2020
Q3 | $361K | Buy |
+2,666
| New | +$361K | 0.13% | 60 |
|
|
2017
Q3 | – | Sell |
-11,871
| Closed | -$1.23M | – | 43 |
|
|
2017
Q2 | $1.23M | Buy |
11,871
+1,059
| +10% | +$109K | 0.45% | 36 |
|
|
2017
Q1 | $1.06M | Buy |
10,812
+1,287
| +14% | +$126K | 0.4% | 34 |
|
|
2016
Q4 | $843K | Buy |
+9,525
| New | +$843K | 0.33% | 39 |
|
|
2016
Q2 | – | Sell |
-30,000
| Closed | -$876K | – | 47 |
|
|
2016
Q1 | $876K | Sell |
30,000
-900
| -3% | -$26.3K | 0.45% | 30 |
|
|
2015
Q4 | $1.16M | Buy |
+30,900
| New | +$1.16M | 0.58% | 31 |
|
|
2015
Q3 | – | Sell |
-35,346
| Closed | -$1.46M | – | 57 |
|
|
2015
Q2 | $1.46M | Buy |
35,346
+885
| +3% | +$36.6K | 0.58% | 39 |
|
|
2015
Q1 | $1.36M | Buy |
+34,461
| New | +$1.36M | 0.56% | 39 |
|